Summary: potential of interleukin-2 for the therapy of cancer.
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000302:isolation & purification; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D007376:Interleukin-2